$HBT
HBT Financial Inc

2023 Q2 Form 10-Q Financial Statement

#000155837023007825 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $56.77M $51.78M
YoY Change 58.76% 55.33%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.536M $1.303M
YoY Change 51.48% 29.27%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $7.896M $4.942M
YoY Change 470.52% 251.24%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $25.04M $12.13M
YoY Change 32.24% -34.06%
Income Tax $6.570M $2.923M
% Of Pretax Income 26.23% 24.1%
Net Earnings $18.46M $9.208M
YoY Change 31.08% -32.31%
Net Earnings / Revenue 32.52% 17.78%
Basic Earnings Per Share $0.58 $0.30
Diluted Earnings Per Share $0.58 $0.30
COMMON SHARES
Basic Shares Outstanding 32.04M 32.15M
Diluted Shares Outstanding 32.08M 31.05M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $109.8M $177.1M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $65.03M $65.12M
YoY Change 26.43% 25.22%
Goodwill $59.88M $59.88M
YoY Change 104.2% 104.2%
Intangibles
YoY Change
Long-Term Investments $3.889M $3.594M
YoY Change 24.77% 16.24%
Other Assets $35.00K $235.0K
YoY Change -89.03% -78.26%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $4.976B $5.014B
YoY Change 17.8% 15.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $38.73M $34.92M
YoY Change -24.2% -31.31%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $38.73M $34.92M
YoY Change -24.2% -31.31%
LONG-TERM LIABILITIES
Long-Term Debt $92.20M $92.16M
YoY Change 19.57% 19.59%
Other Long-Term Liabilities $51.94M $50.94M
YoY Change 159.84% 133.24%
Total Long-Term Liabilities $144.1M $143.1M
YoY Change 48.45% 44.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $38.73M $34.92M
Total Long-Term Liabilities $144.1M $143.1M
Total Liabilities $4.525B $4.564B
YoY Change 17.53% 15.08%
SHAREHOLDERS EQUITY
Retained Earnings $241.8M $228.8M
YoY Change 13.77% 12.66%
Common Stock $294.9M $294.4M
YoY Change 32.77% 32.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $450.9M $450.1M
YoY Change
Total Liabilities & Shareholders Equity $4.976B $5.014B
YoY Change 17.8% 15.29%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $18.46M $9.208M
YoY Change 31.08% -32.31%
Depreciation, Depletion And Amortization $1.536M $1.303M
YoY Change 51.48% 29.27%
Cash From Operating Activities $14.64M $21.49M
YoY Change 54.38% 0.84%
INVESTING ACTIVITIES
Capital Expenditures $873.0K $622.0K
YoY Change -521.74% -315.22%
Acquisitions $14.45M
YoY Change
Other Investing Activities -$31.63M $225.7M
YoY Change -63.83% -269.52%
Cash From Investing Activities -$32.51M $225.0M
YoY Change -62.92% -268.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -49.44M -183.6M
YoY Change -59.06% -397.04%
NET CHANGE
Cash From Operating Activities 14.64M 21.49M
Cash From Investing Activities -32.51M 225.0M
Cash From Financing Activities -49.44M -183.6M
Net Change In Cash -67.30M 62.95M
YoY Change -66.17% -225.18%
FREE CASH FLOW
Cash From Operating Activities $14.64M $21.49M
Capital Expenditures $873.0K $622.0K
Free Cash Flow $13.77M $20.87M
YoY Change 42.07% -3.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
871000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50469000
CY2023Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
235000
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
235000
CY2023Q1 us-gaap Foreclosed Assets
ForeclosedAssets
3356000
CY2022Q4 us-gaap Foreclosed Assets
ForeclosedAssets
3030000
CY2023Q1 us-gaap Mortgage Servicing Rights Msr Impairment Recovery
MortgageServicingRightsMSRImpairmentRecovery
624000
CY2023Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
3545000
CY2023Q1 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
9341000
CY2023Q1 us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
622000
CY2022Q1 us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
289000
CY2023Q1 hbt Proceeds From Sale Of Premises And Equipments
ProceedsFromSaleOfPremisesAndEquipments
7000
CY2022Q1 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
568000
CY2023Q1 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
40000
CY2022Q1 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
294000
CY2023Q1 hbt Debt Securities Available For Sale Accrued Interest
DebtSecuritiesAvailableForSaleAccruedInterest
6300000
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1117216
CY2022Q4 us-gaap Debt Securities Pledged Status Extensible Enumeration
DebtSecuritiesPledgedStatusExtensibleEnumeration
http://fasb.org/us-gaap/2022#AssetPledgedAsCollateralMember
CY2022Q1 hbt Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
0
CY2023Q1 hbt Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
0
CY2023Q1 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
CY2022Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000775215
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 hbt Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
0
CY2023Q1 hbt Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
0
CY2022Q1 hbt Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Into Level31
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel31
0
CY2023Q1 hbt Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Into Level31
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel31
0
CY2022Q1 hbt Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Out Of Level31
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel31
0
CY2023Q1 hbt Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Out Of Level31
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel31
0
CY2022Q1 hbt Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
0
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-39085
CY2023Q1 hbt Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
0
CY2022Q1 hbt Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level31
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel31
0
CY2023Q1 hbt Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level31
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel31
0
CY2022Q1 hbt Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level31
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel31
0
CY2023Q1 hbt Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level31
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel31
0
CY2023Q1 us-gaap Debt Securities Pledged Status Extensible Enumeration
DebtSecuritiesPledgedStatusExtensibleEnumeration
http://fasb.org/us-gaap/2022#AssetPledgedAsCollateralMember
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
HBT Financial, Inc.
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
401 North Hershey Rd
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Bloomington
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
61704
CY2023Q1 dei City Area Code
CityAreaCode
888
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
897-2276
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
HBT
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32040881
CY2023Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
35244000
CY2022Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
18970000
CY2023Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
141868000
CY2022Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
95189000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
177112000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114159000
CY2023Q1 hbt Interest Bearing Deposit Time Deposits With Banks
InterestBearingDepositTimeDepositsWithBanks
249000
CY2023Q1 us-gaap Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
600000
CY2023Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
854622000
CY2022Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
843524000
CY2023Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
481925000
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
478801000
CY2023Q1 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss
536429000
CY2022Q4 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss
541600000
CY2023Q1 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
3145000
CY2022Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
3029000
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1980000
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1977000
CY2023Q1 us-gaap Restricted Investments
RestrictedInvestments
4991000
CY2022Q4 us-gaap Restricted Investments
RestrictedInvestments
7965000
CY2023Q1 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
5130000
CY2022Q4 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
615000
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
3195540000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
2620253000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
38776000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
25333000
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
3156764000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
2594920000
CY2023Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
23447000
CY2022Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
7557000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
65119000
CY2023Q1 us-gaap Goodwill
Goodwill
59876000
CY2022Q4 us-gaap Goodwill
Goodwill
29322000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
22842000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1070000
CY2023Q1 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
19992000
CY2022Q4 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
10147000
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
1614000
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
1165000
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
20301000
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
19506000
CY2023Q1 us-gaap Other Assets
OtherAssets
56617000
CY2022Q4 us-gaap Other Assets
OtherAssets
56444000
CY2023Q1 us-gaap Assets
Assets
5013821000
CY2022Q4 us-gaap Assets
Assets
4286734000
CY2023Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
1218888000
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
994954000
CY2023Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
3091633000
CY2022Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
2592070000
CY2023Q1 us-gaap Deposits
Deposits
4310521000
CY2022Q4 us-gaap Deposits
Deposits
3587024000
CY2023Q1 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
34919000
CY2022Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
43081000
CY2023Q1 us-gaap Federal Home Loan Bank Advances Maturities Summary Due Within One Year Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueWithinOneYearOfBalanceSheetDate
75183000
CY2022Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due Within One Year Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueWithinOneYearOfBalanceSheetDate
160000000
CY2023Q1 us-gaap Subordinated Debt
SubordinatedDebt
39415000
CY2022Q4 us-gaap Subordinated Debt
SubordinatedDebt
39395000
CY2023Q1 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
52746000
CY2022Q4 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
37780000
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
50939000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
45822000
CY2023Q1 us-gaap Liabilities
Liabilities
4563723000
CY2022Q4 us-gaap Liabilities
Liabilities
3913102000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32730698
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29308491
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32095370
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28752626
CY2023Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
327000
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
293000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
294441000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
222783000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
228782000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
232004000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-62175000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-71759000
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
635328
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
555865
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
11277000
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
9689000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
450098000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
373632000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5013821000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4286734000
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
42159000
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
26806000
CY2023Q1 hbt Interest And Fee Income Loans Federally Tax Exempt
InterestAndFeeIncomeLoansFederallyTaxExempt
952000
CY2022Q1 hbt Interest And Fee Income Loans Federally Tax Exempt
InterestAndFeeIncomeLoansFederallyTaxExempt
662000
CY2023Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
6616000
CY2022Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
4649000
CY2023Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
1197000
CY2022Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
1040000
CY2023Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
739000
CY2022Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
159000
CY2023Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
116000
CY2022Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
19000
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
51779000
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
33335000
CY2023Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
2374000
CY2022Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
569000
CY2023Q1 us-gaap Interest Expense Securities Sold Under Agreements To Repurchase
InterestExpenseSecuritiesSoldUnderAgreementsToRepurchase
38000
CY2022Q1 us-gaap Interest Expense Securities Sold Under Agreements To Repurchase
InterestExpenseSecuritiesSoldUnderAgreementsToRepurchase
9000
CY2023Q1 hbt Interest Expense On Borrowings Other Than Securities Sold Under Agreements To Repurchase And Subordinated Notes And Debentures
InterestExpenseOnBorrowingsOtherThanSecuritiesSoldUnderAgreementsToRepurchaseAndSubordinatedNotesAndDebentures
1297000
CY2022Q1 hbt Interest Expense On Borrowings Other Than Securities Sold Under Agreements To Repurchase And Subordinated Notes And Debentures
InterestExpenseOnBorrowingsOtherThanSecuritiesSoldUnderAgreementsToRepurchaseAndSubordinatedNotesAndDebentures
1000
CY2023Q1 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
470000
CY2022Q1 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
470000
CY2023Q1 us-gaap Interest Expense Junior Subordinated Debentures
InterestExpenseJuniorSubordinatedDebentures
763000
CY2022Q1 us-gaap Interest Expense Junior Subordinated Debentures
InterestExpenseJuniorSubordinatedDebentures
358000
CY2023Q1 us-gaap Interest Expense
InterestExpense
4942000
CY2022Q1 us-gaap Interest Expense
InterestExpense
1407000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
46837000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
31928000
CY2023Q1 hbt Provision For Loan Losses Expensed Plus Adjustments For Purchased Credit Deteriorated Loans
ProvisionForLoanLossesExpensedPlusAdjustmentsForPurchasedCreditDeterioratedLoans
6210000
CY2022Q1 hbt Provision For Loan Losses Expensed Plus Adjustments For Purchased Credit Deteriorated Loans
ProvisionForLoanLossesExpensedPlusAdjustmentsForPurchasedCreditDeterioratedLoans
-584000
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
40627000
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
32512000
CY2023Q1 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
1099000
CY2022Q1 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
658000
CY2022Q1 us-gaap Mortgage Servicing Rights Msr Impairment Recovery
MortgageServicingRightsMSRImpairmentRecovery
-1729000
CY2023Q1 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
276000
CY2022Q1 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
587000
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
-1007000
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-22000
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-187000
CY2023Q1 hbt Gains Losses On Foreclosed Assets
GainsLossesOnForeclosedAssets
-10000
CY2022Q1 hbt Gains Losses On Foreclosed Assets
GainsLossesOnForeclosedAssets
40000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
193000
CY2023Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
115000
CY2022Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
40000
CY2023Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
743000
CY2022Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
638000
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
7437000
CY2022Q1 us-gaap Noninterest Income
NoninterestIncome
10043000
CY2023Q1 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
19411000
CY2022Q1 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
12801000
CY2023Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2335000
CY2022Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2444000
CY2023Q1 us-gaap Occupancy Net
OccupancyNet
2102000
CY2022Q1 us-gaap Occupancy Net
OccupancyNet
2060000
CY2023Q1 us-gaap Equipment Expense
EquipmentExpense
659000
CY2022Q1 us-gaap Equipment Expense
EquipmentExpense
552000
CY2023Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
4323000
CY2022Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1653000
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
836000
CY2022Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
851000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
510000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
245000
CY2023Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
563000
CY2022Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
288000
CY2023Q1 us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
278000
CY2022Q1 us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
157000
CY2023Q1 us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
61000
CY2022Q1 us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
132000
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
4855000
CY2022Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2974000
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
35933000
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
24157000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12131000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18398000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2923000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4794000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9208000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
13604000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30977204
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28986593
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9208000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
13604000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
11443000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-53422000
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-1607000
CY2023Q1 hbt Other Comprehensive Income Loss Reclassification Adjustment From Unrealized Gain Loss On Investment Transferred From Available For Sale To Held To Maturity
OtherComprehensiveIncomeLossReclassificationAdjustmentFromUnrealizedGainLossOnInvestmentTransferredFromAvailableForSaleToHeldToMaturity
490000
CY2022Q1 hbt Other Comprehensive Income Loss Reclassification Adjustment From Unrealized Gain Loss On Investment Transferred From Available For Sale To Held To Maturity
OtherComprehensiveIncomeLossReclassificationAdjustmentFromUnrealizedGainLossOnInvestmentTransferredFromAvailableForSaleToHeldToMaturity
181000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-40000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
594000
CY2023Q1 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
94000
CY2022Q1 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
-96000
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
13406000
CY2022Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-52551000
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
3822000
CY2022Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-14980000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
9584000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-37571000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18792000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23967000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
373632000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9208000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9584000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
517000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-181000
CY2023Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
71356000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1588000
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.17
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
5508000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
450098000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
411881000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
13604000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-37571000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
901000
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-57000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
943000
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
4660000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
383155000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
9208000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
13604000
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
793000
CY2022Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
763000
CY2023Q1 hbt Provision For Loan Losses Expensed Plus Adjustments For Purchased Credit Deteriorated Loans
ProvisionForLoanLossesExpensedPlusAdjustmentsForPurchasedCreditDeterioratedLoans
6210000
CY2022Q1 hbt Provision For Loan Losses Expensed Plus Adjustments For Purchased Credit Deteriorated Loans
ProvisionForLoanLossesExpensedPlusAdjustmentsForPurchasedCreditDeterioratedLoans
-584000
CY2023Q1 hbt Net Amortization Of Debt Securities
NetAmortizationOfDebtSecurities
1518000
CY2022Q1 hbt Net Amortization Of Debt Securities
NetAmortizationOfDebtSecurities
1763000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1079000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
566000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
517000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
901000
CY2023Q1 hbt Accretion Of Discount And Deferred Loan Fees On Loans
AccretionOfDiscountAndDeferredLoanFeesOnLoans
1635000
CY2022Q1 hbt Accretion Of Discount And Deferred Loan Fees On Loans
AccretionOfDiscountAndDeferredLoanFeesOnLoans
1608000
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
-1007000
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-22000
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-187000
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4000
CY2022Q1 hbt Gain Loss On Disposition Of Property Plant Equipment Held For Sale
GainLossOnDispositionOfPropertyPlantEquipmentHeldForSale
197000
CY2023Q1 hbt Foreclosed Asset Gain Loss On Foreclosure
ForeclosedAssetGainLossOnForeclosure
20000
CY2022Q1 hbt Foreclosed Asset Gain Loss On Foreclosure
ForeclosedAssetGainLossOnForeclosure
105000
CY2023Q1 hbt Write Down Of Foreclosed Assets
WriteDownOfForeclosedAssets
30000
CY2022Q1 hbt Write Down Of Foreclosed Assets
WriteDownOfForeclosedAssets
65000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
510000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
245000
CY2023Q1 us-gaap Mortgage Servicing Rights Msr Impairment Recovery
MortgageServicingRightsMSRImpairmentRecovery
624000
CY2022Q1 us-gaap Mortgage Servicing Rights Msr Impairment Recovery
MortgageServicingRightsMSRImpairmentRecovery
-1729000
CY2023Q1 hbt Amortization Of Discounts And Issuance Costs On Subordinated Debt
AmortizationOfDiscountsAndIssuanceCostsOnSubordinatedDebt
37000
CY2022Q1 hbt Amortization Of Discounts And Issuance Costs On Subordinated Debt
AmortizationOfDiscountsAndIssuanceCostsOnSubordinatedDebt
37000
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
69000
CY2022Q1 hbt Amortization Of Premium On Interest Bearing Time Deposits With Banks
AmortizationOfPremiumOnInterestBearingTimeDepositsWithBanks
3000
CY2023Q1 hbt Amortization Of Premium On Time Deposits
AmortizationOfPremiumOnTimeDeposits
-110000
CY2022Q1 hbt Amortization Of Premium On Time Deposits
AmortizationOfPremiumOnTimeDeposits
-75000
CY2023Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
15734000
CY2022Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
20440000
CY2023Q1 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
13107000
CY2022Q1 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
24192000
CY2023Q1 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
276000
CY2022Q1 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
587000
CY2023Q1 us-gaap Increase Decrease In Insurance Assets
IncreaseDecreaseInInsuranceAssets
108000
CY2022Q1 us-gaap Increase Decrease In Insurance Assets
IncreaseDecreaseInInsuranceAssets
40000
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-2318000
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-1374000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-7846000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1521000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-3364000
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1379000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21490000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21239000
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
145844000
CY2023Q1 us-gaap Proceeds From Maturities Repayments And Calls Of Trading Securities Heldforinvestment
ProceedsFromMaturitiesRepaymentsAndCallsOfTradingSecuritiesHeldforinvestment
26513000
CY2022Q1 us-gaap Proceeds From Maturities Repayments And Calls Of Trading Securities Heldforinvestment
ProceedsFromMaturitiesRepaymentsAndCallsOfTradingSecuritiesHeldforinvestment
41117000
CY2023Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
51000
CY2022Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
189744000
CY2023Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
-61964000
CY2022Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
-14649000
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
14454000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
225037000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-133405000
CY2023Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
3190000
CY2022Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
77959000
CY2023Q1 us-gaap Increase Decrease In Federal Funds Purchased And Securities Sold Under Agreements To Repurchase Net
IncreaseDecreaseInFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchaseNet
-8162000
CY2022Q1 us-gaap Increase Decrease In Federal Funds Purchased And Securities Sold Under Agreements To Repurchase Net
IncreaseDecreaseInFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchaseNet
-10422000
CY2023Q1 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
171325000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
181000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
57000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1588000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
943000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5508000
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4660000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-183574000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
61877000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
62953000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-50289000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114159000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
409268000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
177112000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
358979000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
4903000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
1890000
CY2023Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
105000
CY2022Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
19000
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-line:none;">Use of Estimates</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The accompanying consolidated financial statements have been prepared in conformity with GAAP. In preparing the financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet and the reported results of operations for the periods then ended.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Actual results could differ significantly from those estimates. Material estimates that are particularly susceptible to significant changes in the near term relate to the determination of the allowance for credit losses and fair value of assets acquired and liabilities assumed in business combinations.</p>
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-line:none;">Reclassifications</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Certain prior period amounts have been reclassified to conform to the current period presentation without any impact on the reported amounts of net income or stockholders’ equity.</p>
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
25333000
CY2023Q1 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
933104000
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
138000
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
78020000
CY2023Q1 us-gaap Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
600000
CY2023Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
854622000
CY2023Q1 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss
536429000
CY2023Q1 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
426000
CY2023Q1 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
54930000
CY2023Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
481925000
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
934456000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
106000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
91038000
CY2022Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
843524000
CY2022Q4 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss
541600000
CY2022Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
195000
CY2022Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
62994000
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
478801000
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
49926000
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
47935000
CY2022Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
73819000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
4825000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
171514000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
73156000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
653146000
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
77981000
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
824660000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
37977000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
531226000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
53061000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
299159000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
91038000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
830385000
CY2022Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
22823000
CY2022Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
220934000
CY2022Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
40171000
CY2022Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
239252000
CY2022Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
62994000
CY2022Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue
460186000
CY2022Q4 hbt Debt Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
60800000
CY2022Q4 hbt Debt Securities Continuous Unrealized Loss Position Less Than12 Months Fair Value
DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsFairValue
752160000
CY2022Q4 hbt Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
93232000
CY2022Q4 hbt Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Fair Value
DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerFairValue
538411000
CY2022Q4 hbt Debt Securities Unrealized Loss Position Accumulated Loss
DebtSecuritiesUnrealizedLossPositionAccumulatedLoss
154032000
CY2022Q4 hbt Debt Securities Unrealized Loss Position Fair Value
DebtSecuritiesUnrealizedLossPositionFairValue
1290571000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
531
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
316
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
145844000
CY2023Q1 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
1007000
CY2023Q1 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
3142000
CY2023Q1 hbt Equity Securities No Readily Determinable Fair Value Cost
EquitySecuritiesNoReadilyDeterminableFairValueCost
2283000
CY2023Q1 hbt Equity Securities Fv Ni Unrealized Gain Loss Cumulative
EquitySecuritiesFvNiUnrealizedGainLossCumulative
3000
CY2023Q1 hbt Equity Securities No Readily Determinable Fair Value Unrealized Gain Loss Cumulative
EquitySecuritiesNoReadilyDeterminableFairValueUnrealizedGainLossCumulative
-303000
CY2023Q1 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
3145000
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1980000
CY2022Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
3142000
CY2022Q4 hbt Equity Securities No Readily Determinable Fair Value Cost
EquitySecuritiesNoReadilyDeterminableFairValueCost
2142000
CY2022Q4 hbt Equity Securities Fv Ni Unrealized Gain Loss Cumulative
EquitySecuritiesFvNiUnrealizedGainLossCumulative
-113000
CY2022Q4 hbt Equity Securities No Readily Determinable Fair Value Unrealized Gain Loss Cumulative
EquitySecuritiesNoReadilyDeterminableFairValueUnrealizedGainLossCumulative
-165000
CY2022Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
3029000
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1977000
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
100000
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
200000
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
0
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
0
CY2022Q1 us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
0
CY2023Q1 us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
0
CY2023Q1 hbt Equity Securities Readily Determinable Fair Value Unrealized Gain Loss
EquitySecuritiesReadilyDeterminableFairValueUnrealizedGainLoss
116000
CY2022Q1 hbt Equity Securities Readily Determinable Fair Value Unrealized Gain Loss
EquitySecuritiesReadilyDeterminableFairValueUnrealizedGainLoss
-187000
CY2023Q1 hbt Equity Securities Without Readily Determinable Fair Value Unrealized Gain Loss
EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss
-138000
CY2023Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-22000
CY2022Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-187000
CY2022Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
71715000
CY2022Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
6320000
CY2022Q1 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
26727000
CY2022Q1 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
267000
CY2022Q1 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
61545000
CY2022Q1 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
604000
CY2022Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
88272000
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
3195540000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
2620253000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
38776000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
25333000
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
3156764000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
2594920000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
25333000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase
FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease
1247000
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
5101000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
142000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
254000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
38776000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
23936000
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-584000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
134000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
1290000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
24508000
CY2023Q1 hbt Financing Receivable Allowance For Credit Loss Gross Write Offs Against Amounts Originated In Current Fiscal Year
FinancingReceivableAllowanceForCreditLossGrossWriteOffsAgainstAmountsOriginatedInCurrentFiscalYear
35000
CY2023Q1 hbt Financing Receivable Allowance For Credit Loss Gross Write Offs Against Amounts Originated In Fiscal Year Prior To Current Fiscal Year
FinancingReceivableAllowanceForCreditLossGrossWriteOffsAgainstAmountsOriginatedInFiscalYearPriorToCurrentFiscalYear
56000
CY2023Q1 hbt Financing Receivable Allowance For Credit Loss Gross Write Offs Against Amounts Originated Three Years Prior To Current Fiscal Year
FinancingReceivableAllowanceForCreditLossGrossWriteOffsAgainstAmountsOriginatedThreeYearsPriorToCurrentFiscalYear
9000
CY2023Q1 hbt Financing Receivable Allowance For Credit Loss Gross Write Offs Against Amounts Originated Four Years Prior To Current Fiscal Year
FinancingReceivableAllowanceForCreditLossGrossWriteOffsAgainstAmountsOriginatedFourYearsPriorToCurrentFiscalYear
1000
CY2023Q1 hbt Financing Receivable Allowance For Credit Loss Gross Write Offs Against Amounts Originated Five Or More Years Prior To Current Fiscal Year
FinancingReceivableAllowanceForCreditLossGrossWriteOffsAgainstAmountsOriginatedFiveOrMoreYearsPriorToCurrentFiscalYear
21000
CY2023Q1 hbt Financing Receivable Allowance For Credit Loss Gross Write Offs Against Revolving Loans
FinancingReceivableAllowanceForCreditLossGrossWriteOffsAgainstRevolvingLoans
20000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
142000
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
3195540000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
38776000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
2620253000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
25333000
CY2023Q1 us-gaap Financing Receivable Accrued Interest Before Allowance For Credit Loss
FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss
13800000
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
23893000
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
23780000
CY2022Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
6320000
CY2021Q4 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYield
413000
CY2022Q1 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield Reclassifications From Nonaccretable Difference
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYieldReclassificationsFromNonaccretableDifference
117000
CY2022Q1 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield Accretion
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYieldAccretion
46000
CY2022Q1 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYield
484000
CY2023Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
6508000
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
3195540000
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
2155000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
2620253000
CY2023Q1 hbt Financing Receivable Excluding Accrued Interest Non Accrual With Allowance For Credit Losses
FinancingReceivableExcludingAccruedInterestNonAccrualWithAllowanceForCreditLosses
732000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Nonaccrual No Allowance
FinancingReceivableExcludingAccruedInterestNonaccrualNoAllowance
5776000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Nonaccrual
FinancingReceivableExcludingAccruedInterestNonaccrual
6508000
CY2023Q1 hbt Internal Review Threshold
InternalReviewThreshold
750000
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
3195540000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
2620253000
CY2023Q1 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
181664000
CY2023Q1 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
902526000
CY2023Q1 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
732456000
CY2023Q1 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
417489000
CY2023Q1 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
233680000
CY2023Q1 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
323843000
CY2023Q1 us-gaap Financing Receivable Revolving
FinancingReceivableRevolving
375236000
CY2023Q1 us-gaap Financing Receivable Revolving Converted To Term Loan
FinancingReceivableRevolvingConvertedToTermLoan
28646000
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
3195540000
CY2023Q1 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2022Q1 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2022Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
3000000.0
CY2022Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
3030000
CY2021Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
3278000
CY2023Q1 hbt Foreclosed Assets Acquired
ForeclosedAssetsAcquired
271000
CY2023Q1 us-gaap Transfer Of Other Real Estate
TransferOfOtherRealEstate
105000
CY2022Q1 us-gaap Transfer Of Other Real Estate
TransferOfOtherRealEstate
19000
CY2023Q1 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
40000
CY2022Q1 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
294000
CY2023Q1 hbt Foreclosed Asset Gain Loss On Sale
ForeclosedAssetGainLossOnSale
20000
CY2022Q1 hbt Foreclosed Asset Gain Loss On Sale
ForeclosedAssetGainLossOnSale
105000
CY2023Q1 hbt Foreclosed Asset Direct Write Downs
ForeclosedAssetDirectWriteDowns
30000
CY2022Q1 hbt Foreclosed Asset Direct Write Downs
ForeclosedAssetDirectWriteDowns
65000
CY2023Q1 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
3356000
CY2022Q1 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
3043000
CY2022Q4 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
92600000
CY2023Q1 hbt Foreclosed Asset Direct Write Downs
ForeclosedAssetDirectWriteDowns
30000
CY2022Q1 hbt Foreclosed Asset Direct Write Downs
ForeclosedAssetDirectWriteDowns
65000
CY2023Q1 hbt Foreclosed Asset Gain Loss On Sale
ForeclosedAssetGainLossOnSale
20000
CY2022Q1 hbt Foreclosed Asset Gain Loss On Sale
ForeclosedAssetGainLossOnSale
105000
CY2023Q1 hbt Gains Losses On Foreclosed Assets
GainsLossesOnForeclosedAssets
-10000
CY2022Q1 hbt Gains Losses On Foreclosed Assets
GainsLossesOnForeclosedAssets
40000
CY2023Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
1218888000
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
994954000
CY2023Q1 us-gaap Demand Deposit Accounts
DemandDepositAccounts
1270454000
CY2022Q4 us-gaap Demand Deposit Accounts
DemandDepositAccounts
1139150000
CY2023Q1 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
662088000
CY2022Q4 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
555425000
CY2023Q1 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
738719000
CY2022Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
634527000
CY2023Q1 us-gaap Time Deposits
TimeDeposits
420372000
CY2022Q4 us-gaap Time Deposits
TimeDeposits
262968000
CY2023Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
3091633000
CY2022Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
2592070000
CY2023Q1 us-gaap Deposits
Deposits
4310521000
CY2022Q4 us-gaap Deposits
Deposits
3587024000
CY2023Q1 us-gaap Interest Bearing Domestic Deposit Brokered
InterestBearingDomesticDepositBrokered
0
CY2022Q4 us-gaap Interest Bearing Domestic Deposit Brokered
InterestBearingDomesticDepositBrokered
0
CY2023Q1 hbt Reciprocal Transaction Deposits Interest Bearing Demand Deposits
ReciprocalTransactionDepositsInterestBearingDemandDeposits
40400000
CY2023Q1 hbt Money Market Deposits Reciprocal Transaction Deposits
MoneyMarketDepositsReciprocalTransactionDeposits
10100000
CY2022Q4 hbt Money Market Deposits Reciprocal Transaction Deposits
MoneyMarketDepositsReciprocalTransactionDeposits
1700000
CY2023Q1 hbt Time Deposits Reciprocal Transaction Deposits
TimeDepositsReciprocalTransactionDeposits
45500000
CY2022Q4 hbt Time Deposits Reciprocal Transaction Deposits
TimeDepositsReciprocalTransactionDeposits
1600000
CY2023Q1 hbt Time Deposits250000 Or More
TimeDeposits250000OrMore
59800000
CY2022Q4 hbt Time Deposits250000 Or More
TimeDeposits250000OrMore
27200000
CY2023Q1 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
202300000
CY2023Q1 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
458000
CY2022Q1 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
142000
CY2023Q1 us-gaap Interest Expense Money Market Deposits
InterestExpenseMoneyMarketDeposits
935000
CY2022Q1 us-gaap Interest Expense Money Market Deposits
InterestExpenseMoneyMarketDeposits
121000
CY2023Q1 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
178000
CY2022Q1 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
50000
CY2023Q1 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
803000
CY2022Q1 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
256000
CY2023Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
2374000
CY2022Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
569000
CY2023Q1 hbt Number Of Subsidiary
NumberOfSubsidiary
8
CY2023Q1 hbt Maximum Deferred Period Of Interest Quarters
MaximumDeferredPeriodOfInterestQuarters
20
CY2023Q1 hbt Shorten Of Maturity Date Trigger Date Event Of Change In Tax Or Capital Treatment
ShortenOfMaturityDateTriggerDateEventOfChangeInTaxOrCapitalTreatment
P90D
CY2022Q1 hbt Percentage Of Trust Preferred Securities Qualified As Tier1 Capital
PercentageOfTrustPreferredSecuritiesQualifiedAsTier1Capital
1
CY2023Q1 hbt Percentage Of Trust Preferred Securities Qualified As Tier1 Capital
PercentageOfTrustPreferredSecuritiesQualifiedAsTier1Capital
1
CY2023Q1 us-gaap Cash
Cash
600000
CY2022Q4 us-gaap Cash
Cash
600000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9208000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
13604000
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
5000
CY2022Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
17000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9203000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
9203000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13587000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
13587000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30977204
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28986593
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
69947
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
43646
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31047151
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29030239
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
518000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
878000
CY2022Q1 hbt Vesting Percentage Of Unvested Restricted Stock Units And Performance Restricted Stock Units If Retirement Eligibility Requirements Are Met
VestingPercentageOfUnvestedRestrictedStockUnitsAndPerformanceRestrictedStockUnitsIfRetirementEligibilityRequirementsAreMet
1
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
600000
CY2023Q1 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.025
CY2022Q4 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.025
CY2022Q1 hbt Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2023Q1 hbt Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0

Files In Submission

Name View Source Status
0001558370-23-007825-index-headers.html Edgar Link pending
0001558370-23-007825-index.html Edgar Link pending
0001558370-23-007825.txt Edgar Link pending
0001558370-23-007825-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hbt-20230331.xsd Edgar Link pending
hbt-20230331x10q.htm Edgar Link pending
hbt-20230331xex31d1.htm Edgar Link pending
hbt-20230331xex31d2.htm Edgar Link pending
hbt-20230331xex32d1.htm Edgar Link pending
hbt-20230331xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
hbt-20230331_def.xml Edgar Link unprocessable
hbt-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
hbt-20230331_pre.xml Edgar Link unprocessable
hbt-20230331_lab.xml Edgar Link unprocessable
hbt-20230331x10q_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending